悦康药业创新引擎驱动，开启医药高质量发展新征程

iDoNews2025-04-30

近日，医药行业再传捷报，悦康药业集团研发的预防呼吸道合胞病毒（RSV）的mRNA疫苗YKYY025注射液成功获得美国食品药品监督管理局（FDA）临床试验批准。这一里程碑式突破，不仅彰显了悦康药业在核酸药物研发领域的卓越实力，更标志着其以创新为核心驱动力，加速迈向全球医药创新前沿。创新研发是悦康药业发展的“最强引擎”。面对AI重塑医疗行业格局的趋势，悦康药业率先布局，打造全流程AI药物研发平台。依托...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2531411728?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-30 10:08","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2531411728","market":"sh","top_or_hot":-1,"title":"悦康药业创新引擎驱动，开启医药高质量发展新征程","media":"iDoNews","content":"<div>\n<p>近日，医药行业再传捷报，悦康药业集团研发的预防呼吸道合胞病毒（RSV）的mRNA疫苗YKYY025注射液成功获得美国食品药品监督管理局（FDA）临床试验批准。这一里程碑式突破，不仅彰显了悦康药业在核酸药物研发领域的卓越实力，更标志着其以创新为核心驱动力，加速迈向全球医药创新前沿。创新研发是悦康药业发展的“最强引擎”。面对AI重塑医疗行业格局的趋势，悦康药业率先布局，打造全流程AI药物研发平台。依托...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010115994e84651&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>悦康药业创新引擎驱动，开启医药高质量发展新征程</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n悦康药业创新引擎驱动，开启医药高质量发展新征程\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-30 10:08 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010115994e84651&s=b><strong>iDoNews</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，医药行业再传捷报，悦康药业集团研发的预防呼吸道合胞病毒（RSV）的mRNA疫苗YKYY025注射液成功获得美国食品药品监督管理局（FDA）临床试验批准。这一里程碑式突破，不仅彰显了悦康药业在核酸药物研发领域的卓越实力，更标志着其以创新为核心驱动力，加速迈向全球医药创新前沿。创新研发是悦康药业发展的“最强引擎”。面对AI重塑医疗行业格局的趋势，悦康药业率先布局，打造全流程AI药物研发平台。依托...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010115994e84651&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"399050","symbol_name":"创新引擎","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010115994e84651&s=b","article_id":"2531411728","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025043010115994e84651&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2531411728","pubTimestamp":1745978889,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"面对AI重塑医疗行业格局的趋势，悦康药业率先布局，打造全流程AI药物研发平台。未来，悦康药业将继续以创新为笔，在医药领域书写高质量发展的崭新篇章，向着成为全球医药创新领军企业的目标奋勇前行。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159938":"医药","399050":"创新引擎","688658":"悦康药业","BK0239":"医药制造"},"translate_title":"Driven by the innovation engine of Yuekang Pharmaceutical, it starts a new journey of high-quality medical development","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159938":1,"399050":1,"688658":1},"content_text":"近日，医药行业再传捷报，悦康药业集团研发的预防呼吸道合胞病毒（RSV）的mRNA疫苗YKYY025注射液成功获得美国食品药品监督管理局（FDA）临床试验批准。这一里程碑式突破，不仅彰显了悦康药业在核酸药物研发领域的卓越实力，更标志着其以创新为核心驱动力，加速迈向全球医药创新前沿。创新研发是悦康药业发展的“最强引擎”。面对AI重塑医疗行业格局的趋势，悦康药业率先布局，打造全流程AI药物研发平台。依托前沿大模型构建自主知识产权的AI算法，该平台广泛应用于靶点发现、药物设计等多个关键环节，有效降低研发成本，大幅提升研发效率与成功率。目前，悦康药业已在AI药物研发领域斩获10项授权专利，并发表2篇高质量论文，首款基于AI设计的创新药YKYY018也蓄势待发，有望于今年申报临床，展现出强大的创新转化能力。在创新技术的探索上，悦康药业始终走在行业前列。通过与华为达成战略合作，共建数字化转型升级建设项目，进一步推动研发体系提质增效。此前，企业已完成制药车间和生产线的智能升级改造，荣获“国家智能制造试点示范企业”和“全国绿色制造体系建设示范企业‘绿色工厂’”称号，实现了从传统制药向智能化、绿色化的华丽转型。创新不仅体现在技术层面，更贯穿于悦康药业的产品与质量把控中。在产品细节上，企业不断推陈出新，如采用瓶盖内置干燥剂设计，既避免污染风险，又提升防伪性能。在质量把控上，悦康药业首创“药品全过程动态质量管理模式”，坚持内控标准高于国家标准，以奥美拉唑肠溶胶囊为例，单产品就设置200余项质量检验项目。严苛的质量管控，让其70余个品规的产品成功出口至全球50多个国家和地区，实现药品质量与国际接轨。作为中国医药工业百强企业，悦康药业以创新研发为核心，全产业链生态为支撑，在“健康中国”战略指引下，持续以硬核科技实力和对质量与创新的坚守，为全球患者提供更优解决方案。未来，悦康药业将继续以创新为笔，在医药领域书写高质量发展的崭新篇章，向着成为全球医药创新领军企业的目标奋勇前行。声明：本站转载此文目的在于传递更多信息，并不代表赞同其观点和对其真实性负责。如涉及作品内容、版权和其它问题，请在30日内与本网联系，我们将在第一时间删除内容,本网站对此声明具有最终解释权。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2531411728","isCrawlerRequest":true}